Guangdong Jiaying Pharmaceutical Co Ltd (002198) — Cash Flow Reinvestment Rate
Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Cash Flow Reinvestment Rate of 0.13x as of December 2024, reinvesting CN¥5.65 Million (capex CN¥4.57 Million plus investments CN¥1.08 Million) from operating cash flow of CN¥43.63 Million. See 002198 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2004–2025)
Historical reinvestment intensity for Guangdong Jiaying Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Guangdong Jiaying Pharmaceutical Co Ltd.
Annual Cash Flow Reinvestment Rate for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Year-by-year capital reinvestment analysis for Guangdong Jiaying Pharmaceutical Co Ltd. See 002198 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 15.57x | CN¥140.15 Million | CN¥9.00 Million | CN¥109.92 Million | ▲ +2067.8% |
| 2024 | 0.72x | CN¥43.70 Million | CN¥60.85 Million | CN¥38.70 Million | ▲ +738.6% |
| 2023 | 0.09x | CN¥8.43 Million | CN¥98.45 Million | CN¥5.06 Million | ▼ -95.7% |
| 2022 | 1.98x | CN¥53.77 Million | CN¥27.15 Million | CN¥2.74 Million | ▲ +194.4% |
| 2021 | 0.67x | CN¥34.84 Million | CN¥51.80 Million | CN¥2.34 Million | ▲ +115.9% |
| 2020 | 0.31x | CN¥30.18 Million | CN¥96.87 Million | CN¥11.68 Million | ▼ -96.2% |
| 2019 | 8.11x | CN¥105.13 Million | CN¥12.96 Million | CN¥18.82 Million | ▲ +428.7% |
| 2018 | 1.53x | CN¥95.26 Million | CN¥62.10 Million | CN¥8.95 Million | ▲ +107.1% |
| 2017 | 0.74x | CN¥22.69 Million | CN¥30.63 Million | CN¥18.44 Million | ▲ +171.7% |
| 2016 | 0.27x | CN¥14.48 Million | CN¥53.13 Million | CN¥11.98 Million | ▼ -72.8% |
| 2015 | 1.00x | CN¥42.42 Million | CN¥42.31 Million | CN¥33.42 Million | ▲ +4.9% |
| 2014 | 0.96x | CN¥98.74 Million | CN¥103.36 Million | CN¥98.74 Million | ▲ +113.3% |
| 2013 | 0.45x | CN¥8.72 Million | CN¥19.46 Million | CN¥8.72 Million | ▼ -64.1% |
| 2012 | 1.25x | CN¥6.58 Million | CN¥5.27 Million | CN¥6.58 Million | ▼ -90.9% |
| 2011 | 13.78x | CN¥10.77 Million | CN¥781.89K | CN¥10.77 Million | ▲ +661.8% |
| 2010 | 1.81x | CN¥35.62 Million | CN¥19.70 Million | CN¥35.62 Million | ▼ -34.2% |
| 2009 | 2.75x | CN¥76.95 Million | CN¥27.98 Million | CN¥76.95 Million | ▲ +1.4% |
| 2008 | 2.71x | CN¥29.05 Million | CN¥10.71 Million | CN¥29.05 Million | ▲ +473.6% |
| 2007 | 0.47x | CN¥8.68 Million | CN¥18.35 Million | CN¥8.68 Million | ▼ -3.7% |
| 2006 | 0.49x | CN¥12.95 Million | CN¥26.37 Million | CN¥12.95 Million | ▲ +42.1% |
| 2005 | 0.35x | CN¥6.09 Million | CN¥17.63 Million | CN¥6.09 Million | ▼ -83.2% |
| 2004 | 2.05x | CN¥18.04 Million | CN¥8.78 Million | CN¥18.04 Million | — |